Search Results 961-970 of 16065 for pharmacogenetics

  1. A Study of Individualized Obesity Pharmacotherapy Based on Obesity Phenotypes - Mayo Clinic

    The researchers are trying to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss.

  2. A Study of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study of a Multicomponent Intervention Aimed at Decreasing Perception of Dyspnea in Participants with Lung Disease Who are Obese - Mayo Clinic

    The purpose of this study is to define the feasibility and effectiveness of a multi-component intervention aimed at decreasing perception of dyspnea in ...

  4. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    About this study. Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, ...

  5. Pulmonary Medicine Clinical Trials - Medical Professionals

    The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ...

  6. Discovery and Translation Labs - Mayo Clinic Research

    Researchers in this brain focus area of the Discovery and Translation Labs at Mayo Clinic focus on translational research related to biomarker and drug ...

  7. A Study of Adult Research Cohort with IBD - Mayo Clinic

    About this study. The overarching goal of the Study of a Prospective Research Cohort with Inflammatory Bowel Disease (SPARC IBD) is to create a ...

  8. Biobanking Study in Immunodeficiency Patients - Mayo Clinic

    Primary immunodeficiencies (PID) are diseases that affect any part of multiple components of the immune system, resulting in abnormal and/or impaired immune ...

  9. A Study to Evaluate the Safety and Effectiveness of SPR001 in Adults with Classic Congenital Adrenal Hyperplasia - Mayo Clinic

    The purpose of this study is to evaluate the effect of Tildacerfont in reducing androstenedione (hormone, A4) in subjects with Classic Adrenal Hyperplasia (CAH) ...

  10. clinicaltrials gov.